As of the latest Form 4 filed Oct 15, 2025.
What Quoin Pharmaceuticals Ltd DRC insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 19 most recent filings for QNRX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-15 | 2025-10-14 | LANGER DENNIS Director | PPurchase | +15.2K | $8.49 | $129K | No | Form 4 ↗ |
| 2024-12-27 | 2024-12-23 | Carter Denise P. Chief Operating Officer | PPurchase | +556K | $0.45 | $250K | No | Form 4 ↗ |
| 2024-12-27 | 2024-12-23 | Myers Michael Chief Executive Officer | PPurchase | +556K | $0.45 | $250K | No | Form 4 ↗ |
| 2024-12-27 | 2024-12-23 | Dunn Gordon Chief Financial Officer | PPurchase | +122K | $0.45 | $55.0K | No | Form 4 ↗ |
| 2024-12-27 | 2024-12-23 | Culverwell Anthony James Director | PPurchase | +100K | $0.45 | $45.0K | No | Form 4 ↗ |
| 2024-09-11 | 2024-09-10 | Dunn Gordon Chief Financial Officer | PPurchase | +10.0K | $0.71 | $7.10K | No | Form 4 ↗ |
| 2024-09-11 | 2024-09-10 | Dunn Gordon, Chief Financial Officer | PPurchase | +10.0K | $0.91 | $9.10K | No | Form 4 ↗ |
| 2024-09-11 | 2024-09-09 | Dunn Gordon, Chief Financial Officer | PPurchase | +4.00K | $0.80 | $3.20K | No | Form 4 ↗ |
| 2024-09-11 | 2024-09-09 | Dunn Gordon, Chief Financial Officer | PPurchase | +4.00K | $0.78 | $3.12K | No | Form 4 ↗ |
| 2024-09-11 | 2024-09-09 | Dunn Gordon, Chief Financial Officer | PPurchase | +856.00 | $0.80 | $684.80 | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-04 | Carter Denise P. Chief Operating Officer | PPurchase | +23.0K | $0.80 | $18.3K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-04 | Carter Denise P., Chief Operating Officer | PPurchase | +8.82K | $0.75 | $6.60K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-04 | Myers Michael Chief Executive Officer | PPurchase | +23.6K | $0.80 | $18.8K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-04 | Myers Michael, Chief Executive Officer | PPurchase | +8.20K | $0.75 | $6.13K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-04 | Myers Michael, Chief Executive Officer | PPurchase | +5.32K | $0.66 | $3.49K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-03 | Carter Denise P. Chief Operating Officer | PPurchase | +4.10K | $0.66 | $2.69K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-03 | Carter Denise P., Chief Operating Officer | PPurchase | +1.82K | $0.63 | $1.14K | No | Form 4 ↗ |
| 2024-09-05 | 2024-09-03 | Myers Michael Chief Executive Officer | PPurchase | +800.00 | $0.62 | $495.20 | No | Form 4 ↗ |
| 2024-06-10 | 2024-06-07 | LANGER DENNIS Director | SSale | −297.00 | $0.73 | $217.40 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also QNRX’s full analysis or the market-wide insider trading feed. The tabs above jump to QNRX’s other SEC data.
Source: SEC Form 4 filings for QNRX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.